liver cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient age>=18 years and <=80 years; 2. Primary hepatocellular carcinoma (HCC) confirmed by pathology; 3. Child-Pugh grade A or B; 4. No important symptoms of portal hypertension; 5. ECOG physical performance status score 0-1; 6. Cyberknife treatment can be carried out safely; 7. The patient agrees to undergo follow-up examinations and sign the protocol informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of other malignant tumors in the past 5 years; 2. Patients with severe heart disease, unstable angina, recent myocardial infarction (within 6 months) or severe cardiac insufficiency; 3. Extensive extrahepatic metastasis; 4. Have recently undergone other liver surgery or treatment; 5. Female patients who are currently pregnant or breastfeeding; 6. Patients who do not agree to sign the informed consent of the protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The density of CD8+ T cells and NK cells;The levels of IL-2 and TNF-a;lymph node metastasis incidence; | — |
Countries
China
Contacts
First Hospital of Hebei Medical University